Role of Cytosolic DNA-multiprotein Interactome in Allergic Airway Inflammation
胞浆 DNA-多蛋白相互作用组在过敏性气道炎症中的作用
基本信息
- 批准号:10328563
- 负责人:
- 金额:$ 78.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-10 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllergensAllergicAllergic DiseaseAllergic inflammationAllergic rhinitisAmbrosiaAntibodiesAttenuatedBindingBiopsyCCL11 geneCell NucleusCellsChIP-seqChronic DiseaseComplexCuretteCyclic GMPCytologyCytoplasmDNADNA RepairDNA SequenceDNA glycosylaseDiseaseEngineeringEotaxinEpithelialExtrinsic asthmaFutureGelshift AnalysisGene ExpressionGenomeHumanIRF3 geneImmunoprecipitationInnate Immune ResponseIntranasal AdministrationKnowledgeLeadLengthLocationLungMass Spectrum AnalysisMessenger RNAMonitorMusNamesNoseNuclearNuclear ExtractOligonucleotidesOutcomePeptidesPharmacologyPollenProteinsPulmonary InflammationPunch BiopsyRadiolabeledReactionRecombinantsReportingRespiratory MucosaRoleSamplingSignaling ProteinSiteStimulator of Interferon GenesStructure of mucous membrane of noseTANK-binding kinase 1TestingTimeUp-Regulationairway epitheliumallergic airway inflammationcostcrosslinkcytokineds-DNAextracellularhuman subjectinhibitornoveloxidative DNA damagepreventpromoterpublic health relevancesmall moleculesmall molecule inhibitortranscriptome sequencing
项目摘要
PROJECT SUMMARY/ABSTRACT
Allergic rhinitis and asthma are highly prevalent diseases characterized by allergic airway inflammation. The
airway epithelium is the first line of defense against allergens. We reported that allergenic extracts stimulate
oxidative DNA damage and innate immune responses in these cells. Here we show that cytosolic double
strand (ds)DNA forms a complex with several proteins in the nasal mucosa of humans with allergic rhinitis and
lungs of allergic mice, but not in non-sensitized humans and mice. We named this cytoplasmic DNA-
interactome “Allergosome”. The DNA-interacting proteins in the Allergosome are: interferon regulatory factor 3
(IRF3), the DNA glycosylase Nei-Like 2 (Neil2), and Cyclic GMP-AMP synthase (cGAS). Notably, these factors
associate with Stimulator of Interferon Genes (STING), TANK-binding kinase-1 (TBK1), and the pro-allergic
cytokine IL-33 in the Allergosome. The formation and role of the Allergosome in allergic inflammation are gaps
in knowledge that we address in this proposal. The central hypothesis of this proposal is that “Allergic humans
and mice develop an Allergosome in the cytoplasm of the airway mucosa and lungs that stimulates allergic
airway inflammation”. In Aim 1 we will test the hypothesis that human subjects with allergic rhinitis, but not
healthy control subjects, develop an Allergosome with sequestered IL-33 in nasal mucosal cells. Cytosolic and
crosslinked nuclear extracts will be prepared from the nasal punch biopsies of ragweed-allergic and healthy
subjects. The cytosolic extract of the nasal biopsies will be subjected to immunoprecipitation (IP) with anti-IRF3
antibody, and analyzed for associated DNA sequences by Chip-seq, and for associated proteins in the
Allergosome. In the second Aim, we will test the hypothesis that sequestration of Neil2 in the Allergosome
reduces its ability to protect promoter sites in the genome from binding NFκB and stimulating allergic airway
inflammation. Cytosolic and nuclear extracts will be prepared as in Aim 1. The cytosolic extracts will be
subjected to IP with anti-Neil2 antibody, and analyzed as in Aim 1. The nuclear extracts will be subjected to
ChIP-Seq of the IP’d DNA with anti-Neil2 and anti-NFκB antibodies to determine their promoter occupancy,
and gel shift analysis to detect NFκB binding. Recombinant WT and catalytically inactive Neil2 will be delivered
to the airways of sensitized WT mice by engineered peptide carriers, and allergic inflammation will be
reassessed. In Aim 3, we will test the hypothesis that STING and cGAS stabilize the Allergosome and
stimulate allergic airway inflammation. Allergosome formation and CDE-induced allergic inflammation in WT
mice will be compared to that of StingKO mice, lung epithelium-specific inducible cGasKO mice, and WT mice
treated with pharmacologic cGAS inhibitors. These studies will define, for the first time, the central role of the
Allergosome in allergic airway inflammation. We will provide proof of principle that targeting components of the
Allergosome reduces allergic inflammation. In future studies, these strategies may develop into therapies that
mitigate allergic inflammation in allergic rhinitis and asthma.
项目总结/摘要
变应性鼻炎和哮喘是以变应性气道炎症为特征的高度流行的疾病。的
呼吸道上皮是抵抗过敏原的第一道防线。我们报道了过敏性提取物刺激
氧化DNA损伤和先天性免疫反应。这里我们展示了胞质双
链(ds)DNA与患有过敏性鼻炎的人的鼻粘膜中的几种蛋白质形成复合物,
肺过敏小鼠,但不是在非致敏人类和小鼠。我们把这种细胞质DNA命名为-
相互作用体“过敏体”。过敏小体中的DNA相互作用蛋白质是:干扰素调节因子3
在一些实施方案中,所述糖基化酶包括糖基化酶Nei样2(Neil 2)、糖基化酶IRF 3、DNA糖基化酶Nei样2(Neil 2)和环GMP-AMP合酶(cGAS)。值得注意的是,这些因素
与干扰素基因刺激因子(STING)、TANK结合激酶-1(TBK 1)和促过敏原相关。
过敏小体中的细胞因子IL-33。过敏原体在过敏性炎症中的形成和作用是空白
我们在这份提案中提到的知识。这个提议的核心假设是“过敏的人
小鼠的气道粘膜和肺部的细胞质中产生了过敏小体,
气道炎症”。在目标1中,我们将检验以下假设:患有过敏性鼻炎但未患过敏性鼻炎的人类受试者,
健康对照受试者在鼻粘膜细胞中形成具有隔离的IL-33的过敏体。细胞溶质和
交联核提取物将从豚草过敏和健康的鼻穿孔活检中制备
科目将鼻活检的胞质提取物与抗IRF 3进行免疫沉淀(IP)
抗体,并通过Chip-seq分析相关的DNA序列,并分析抗体中的相关蛋白质。
过敏体在第二个目的中,我们将测试Neil 2在过敏体中的隔离的假设。
降低其保护基因组中启动子位点不与NFκB结合和刺激过敏性气道的能力
炎症将按照目标1制备细胞溶质和细胞核提取物。将细胞溶质提取物
用抗Neil 2抗体进行IP,并如目的1所述进行分析。核提取物将被
用抗Neil 2和抗NF κB抗体对IP处理的DNA进行ChIP-Seq,以确定其启动子占有率,
凝胶位移分析检测NFκB结合。重组WT和无催化活性的Neil 2将被递送
致敏WT小鼠的气道,过敏性炎症将被抑制。
重新评估。在目标3中,我们将检验STING和cGAS稳定过敏体和
刺激过敏性气道炎症。WT中过敏小体形成和CDE诱导的过敏性炎症
小鼠将与StingKO小鼠、肺上皮特异性诱导型cGasKO小鼠和WT小鼠进行比较
用药理学cGAS抑制剂治疗。这些研究将首次确定
过敏性气道炎症中的变态反应体。我们将提供原则证明,
过敏体减少过敏性炎症。在未来的研究中,这些策略可能会发展成为治疗方法,
减轻过敏性鼻炎和哮喘的过敏性炎症。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Intrapulmonary administration of purified NEIL2 abrogates NF-κB-mediated inflammation.
- DOI:10.1016/j.jbc.2021.100723
- 发表时间:2021-01
- 期刊:
- 影响因子:0
- 作者:Tapryal N;Shahabi S;Chakraborty A;Hosoki K;Wakamiya M;Sarkar G;Sharma G;Cardenas VJ;Boldogh I;Sur S;Ghosh G;Hazra TK
- 通讯作者:Hazra TK
Excision release of 5?hydroxycytosine oxidatively induced DNA base lesions from the lung genome by cat dander extract challenge stimulates allergic airway inflammation.
- DOI:10.1111/cea.13284
- 发表时间:2018-12
- 期刊:
- 影响因子:0
- 作者:Hosoki K;Jaruga P;Itazawa T;Aguilera-Aguirre L;Coskun E;Hazra TK;Boldogh I;Dizdaroglu M;Sur S
- 通讯作者:Sur S
Reply.
回复。
- DOI:10.1002/art.40923
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Kim,AlfredHJ;Strand,Vibeke;Atkinson,JohnP
- 通讯作者:Atkinson,JohnP
Nei-like DNA glycosylase 2 selectively antagonizes interferon-β expression upon respiratory syncytial virus infection.
- DOI:10.1016/j.jbc.2023.105028
- 发表时间:2023-08
- 期刊:
- 影响因子:4.8
- 作者:Pan, Lang;Xue, Yaoyao;Wang, Ke;Zheng, Xu;Islam, Azharul;Tapryal, Nisha;Chakraborty, Anirban;Bacsi, Attila;Ba, Xueqing;Hazra, Tapas K.;Boldogh, Istvan
- 通讯作者:Boldogh, Istvan
Protocols to Measure Oxidative Stress and DNA Damage in Asthma.
测量哮喘氧化应激和 DNA 损伤的方案。
- DOI:10.1007/978-1-0716-2364-0_22
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Hosoki,Koa;Chakraborty,Anirban;Hazra,TapasK;Sur,Sanjiv
- 通讯作者:Sur,Sanjiv
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAPAS K HAZRA其他文献
TAPAS K HAZRA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAPAS K HAZRA', 18)}}的其他基金
Mechanism of DNA strand-break repair deficiency in Huntington's disease
亨廷顿病 DNA 链断裂修复缺陷的机制
- 批准号:
9211403 - 财政年份:2016
- 资助金额:
$ 78.97万 - 项目类别:
DNA Double Strand Break Repair Deficiency and Neurodegeneration
DNA 双链断裂修复缺陷和神经退行性变
- 批准号:
9605560 - 财政年份:2012
- 资助金额:
$ 78.97万 - 项目类别:
Preferential single-strand break repair in the active genes of mammalian cells
哺乳动物细胞活性基因的优先单链断裂修复
- 批准号:
8373393 - 财政年份:2012
- 资助金额:
$ 78.97万 - 项目类别:
Preferential single-strand break repair in the active genes of mammalian cells
哺乳动物细胞活性基因的优先单链断裂修复
- 批准号:
8876824 - 财政年份:2012
- 资助金额:
$ 78.97万 - 项目类别:
DNA Double Strand Break Repair Deficiency and Neurodegeneration
DNA 双链断裂修复缺陷和神经退行性变
- 批准号:
9924667 - 财政年份:2012
- 资助金额:
$ 78.97万 - 项目类别:
Preferential single-strand break repair in the active genes of mammalian cells
哺乳动物细胞活性基因的优先单链断裂修复
- 批准号:
9093847 - 财政年份:2012
- 资助金额:
$ 78.97万 - 项目类别:
Preferential single-strand break repair in the active genes of mammalian cells
哺乳动物细胞活性基因的优先单链断裂修复
- 批准号:
8663322 - 财政年份:2012
- 资助金额:
$ 78.97万 - 项目类别:
DNA Double Strand Break Repair Deficiency and Neurodegeneration
DNA 双链断裂修复缺陷和神经退行性变
- 批准号:
10161868 - 财政年份:2012
- 资助金额:
$ 78.97万 - 项目类别:
Preferential single-strand break repair in the active genes of mammalian cells
哺乳动物细胞活性基因的优先单链断裂修复
- 批准号:
8576060 - 财政年份:2012
- 资助金额:
$ 78.97万 - 项目类别:
Preferential single-strand break repair in the active genes of mammalian cells
哺乳动物细胞活性基因的优先单链断裂修复
- 批准号:
8463262 - 财政年份:2012
- 资助金额:
$ 78.97万 - 项目类别:
相似海外基金
Measurement of serum IgE and identification of allergens in seafood allergic patients
海鲜过敏患者血清IgE测定及过敏原鉴定
- 批准号:
21K13490 - 财政年份:2021
- 资助金额:
$ 78.97万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanisms of augmentation of contact allergic reactions by irritants and contact allergens
刺激物和接触性过敏原增强接触性过敏反应的机制
- 批准号:
335858052 - 财政年份:2017
- 资助金额:
$ 78.97万 - 项目类别:
Research Grants
Elucidation of conformational epitopes of peanut allergens essential for allergic reactions
阐明过敏反应所必需的花生过敏原的构象表位
- 批准号:
8970024 - 财政年份:2015
- 资助金额:
$ 78.97万 - 项目类别:
Environmental allergens affect the function of allergic inflammatory cells
环境过敏原影响过敏性炎症细胞的功能
- 批准号:
26860758 - 财政年份:2014
- 资助金额:
$ 78.97万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Effects of allergens on dendritic cell function in allergic asthma
过敏原对过敏性哮喘树突状细胞功能的影响
- 批准号:
nhmrc : 303161 - 财政年份:2004
- 资助金额:
$ 78.97万 - 项目类别:
NHMRC Project Grants
IImmune Tolerance Network: Airborne Allergens and Allergic Rhintitis
II免疫耐受网络:空气中的过敏原和过敏性鼻炎
- 批准号:
8348615 - 财政年份:2001
- 资助金额:
$ 78.97万 - 项目类别:
IImmune Tolerance Network: Airborne Allergens and Allergic Rhintitis
II免疫耐受网络:空气中的过敏原和过敏性鼻炎
- 批准号:
8522031 - 财政年份:2001
- 资助金额:
$ 78.97万 - 项目类别:
IImmune Tolerance Network: Airborne Allergens and Allergic Rhintitis
II免疫耐受网络:空气中的过敏原和过敏性鼻炎
- 批准号:
8730013 - 财政年份:2001
- 资助金额:
$ 78.97万 - 项目类别:
ASPERGILLUS ALLERGENS AND ALLERGIC ASPERGILLOSIS
曲霉过敏原和过敏性曲霉病
- 批准号:
6137243 - 财政年份:1998
- 资助金额:
$ 78.97万 - 项目类别:
ASPERGILLUS ALLERGENS AND ALLERGIC ASPERGILLOSIS
曲霉过敏原和过敏性曲霉病
- 批准号:
2462172 - 财政年份:1998
- 资助金额:
$ 78.97万 - 项目类别: